Aurora Investment Counsel boosted its holdings in Royalty Pharma plc (NASDAQ:RPRX – Free Report) by 7.0% during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 40,558 shares of the biopharmaceutical company’s stock after acquiring an additional 2,656 shares during the quarter. […]
Aurora Investment Counsel boosted its holdings in Royalty Pharma plc (NASDAQ:RPRX – Free Report) by 7.0% during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 40,558 shares of the biopharmaceutical company’s stock after acquiring an additional 2,656 shares during the quarter. […]
Voisard Asset Management Group Inc. purchased a new position in shares of Palo Alto Networks, Inc. (NASDAQ:PANW – Free Report) during the fourth quarter, according to its most recent 13F filing with the SEC. The institutional investor purchased 904 shares of the network technology company’s stock, valued at approximately $267,000. A number of other large […]
Voisard Asset Management Group Inc. bought a new stake in VIZIO Holding Corp. (NYSE:VZIO – Free Report) in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor bought 21,715 shares of the company’s stock, valued at approximately $167,000. Several other institutional investors also recently modified […]
A number of research firms have changed their ratings and price targets for Werewolf Therapeutics (NASDAQ: HOWL): 6/4/2024 – Werewolf Therapeutics had its “market outperform” rating reaffirmed by analysts at JMP Securities. They now have a $12.00 price target on the stock. 6/3/2024 – Werewolf Therapeutics had its “outperform” rating reaffirmed by analysts at Wedbush. […]